How To Reduce Anxiety and Depression By Fixing Nervous System Dysregulation

Discover a powerful, new (and somewhat unpopular) way to deal with anxiety and depression - without meditation, yoga, gratitude lists, pharmaceuticals and $49 Moleskine journals.

Psychedelic Spotlight

Interview With Kelsey Ramsden, President and CEO of Mind Cure

January 7, 2021June 2, 2024 Listen, Podcasts

Kelsey Ramsden, the President, and CEO of Mind Cure Health Inc. sheds light on the advancements Mind Cure is currently making.

Kevin O’Leary Thinks MindMed, Compass Pathways & atai Will Merge | Is this a Good Idea?

April 30, 2022June 2, 2024 Listen, Videos

Get your 20%-off tickets to the Catalyst Psychedelics Summit in Kingston Ontario, May 20th-23rd:
www.eventbrite.ca/e/153409882087/?discount=SPOTLIGHT20

Join our Newsletter (scroll to the bottom of the page and sign up):
https://psychedelicspotlight.com/

Follow us on Twitter:
James: @Psy_Invest
Maria: @psy_holy
The Psychedelic Investor: @PsycInvestor
Psychedelic Spotlight: @PsycSpotlight

Back to the potential MindMed, Compass Pathways & atai merger that Kevin O
Leary speculates on…

Kevin O’Leary Predicts These 3 Psychedelic Companies Will Merge, But Should They?

The “Shark Tank” star predicts three of the biggest psychedelic companies will merge into a mega-corporation, but our resident Psychedelic Investor wonders: Should they?

Famed investor Kevin O’Leary made a bold prediction last Tuesday, saying that psychedelic companies MindMed, atai Life Sciences and Compass Pathways will merge. For psychedelic stock investors, this would be a tsunami-sized event that would have ripple effects throughout the industry.

The Shark Tank star made the comments at the inaugural Benzinga Psychedelics Capital Conference in Miami, arguing that the companies “each need another $200 million by the time they get this to medicine.” In other words, as I have written before, the psychedelic medicines industry is heavily capital intensive, and getting multiple drugs from pre-clinical trials through Phase 3 trials and approved by the FDA can cost hundreds of millions of dollars.

Even though these companies are three of the best-financed in the industry — atai (Nasdaq: atai) has $362 million, Compass (Nasdaq: CMPS) has $273 million and MindMed (Nasdaq: MNMD, NEO: MMED) has $133 million — the celebrity investor believes that in order to succeed the companies may have to become one.

Read the entire article here: https://psychedelicspotlight.com/kevin-oleary-predicts-3-biggest-psychedelic-companies-will-merge-atai-mindmed-compass-pathways/

One man claims magic mushrooms healed his lost sense of smell. Read the full story here.
https://whyy.org/segments/could-magic-mushrooms-cure-covid-related-smell-loss/

A new anti-depressant study is out. Read the full study here: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0265928#sec011

#Mindmed #kevinoleary #psychedelicstocks

First Neuroimaging Study of Psilocybin Microdosing Underway in Sydney

August 16, 2021June 2, 2024 Learn, Microdosing, Research

Researchers hope to establish whether the effects of microdosing are as profound as people say they are, since previous studies could not rule out placebo effect.

Why Psychedelics Could Eventually Treat Asthma

July 12, 2021June 2, 2024 Learn, Research, Treatment

Researchers continue to explore anti-inflammatory nature of psychedelics, which in small doses, may alleviate asthma symptoms.

What Causes Depression? Is it Really a Chemical Imbalance? Here Are Three Other Theories

December 12, 2022June 2, 2024 Education, Learn, Research

Depression is a complex disorder whose onset has been tied to the outdated and contested monoamine theory. It is time to start looking at other possible theories.

Investing in Psychedelic Stocks 101 [ Interview With The Medicine Of Being Human]

February 21, 2021June 2, 2024 Listen, Videos

Hello Psychedelic Investors! As I mentioned in the previous episode of the Psychedelic Investor, last week I had my first ever interview with the wonderful Sena who is interested in creating a resource for those new to investing in psychedelic stocks and investing in stocks in general.
For those interested in the basics on psychedelic investing, you can watch the entire video on:
The Medicine of Being Human :https://www.youtube.com/watch?v=p3d_t4GYG14&t=599s&ab_channel=TheMedicineofBeingHuman

#PsychedelicStocks #MindMed #ThePsychedelicInvestor

I hope you guys found some value in this and I’ll keep you posted for more changes!

Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!

DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.